SCHEMBL7259145

SCHEMBL7259145

O=C(O)CC(Cc1ccc(OCCCNc2nc3ccccc3[nH]2)cc1)c1ccccc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ITGB3 P05106 12/20 0.64
ITGAV P06756 12/20 0.64
ITGB1 P05556 4/20 0.64
ITGB6 P18564 4/20 0.64
ITGB5 P18084 4/20 0.64
ITGA5 P08648 1/20 0.58
NPC1 O15118 3/20 0.50
RAB9A P51151 3/20 0.50
ITGA2B P08514 2/20 0.47
MAPT P10636 1/20 0.47
SMN1; SMN2 Q16637 2/20 0.45
ALDH1A1 P00352 1/20 0.45
TP53 P04637 1/20 0.45
ALOX12 P18054 1/20 0.45
BCHE P06276 1/20 0.45
TRPC3 Q13507 1/20 0.45
TRPC4 Q9UBN4 1/20 0.45
TRPC5 Q9UL62 1/20 0.45
CYSLTR2 Q9NS75 1/20 0.44
CYSLTR1 Q9Y271 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7264202 0.83 ITGB3 (0.70) ITGB3ITGAVITGB1ITGB6ITGB5
SCHEMBL7264402 0.80 ITGB3 (0.65) ITGB3ITGAVITGB1ITGB6ITGB5
SCHEMBL6176984 0.80 ITGB3 (0.80) ITGB3ITGAVITGB1ITGB6ITGB5
SCHEMBL6176988 0.80 ITGB3 (0.80) ITGB3ITGAVITGB1ITGB6ITGB5
SCHEMBL6176963 0.78 ITGB3 (1.00) ITGB3ITGAVITGB1ITGB6ITGB5
SCHEMBL6176936 0.78 ITGB3 (1.00) ITGB3ITGAVITGB1ITGB6ITGB5
SCHEMBL6176461 0.78 ITGB3 (1.00) ITGB3ITGAVITGB1ITGB6ITGB5
SCHEMBL7264764 0.77 ITGB1 (0.51) ITGB1ITGA5NPC1RAB9AMAPT
SCHEMBL7260158 0.77 ITGB3 (0.76) ITGB3ITGAVITGB1ITGB6ITGB5
SCHEMBL7264209 0.77 ITGB3 (0.75) ITGB3ITGAVITGB1ITGB6ITGB5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6645991-B1 Glycoprotein adhesion receptor antagonists such as 3-phenyl-4-(4-(3-(pyridin-2-ylamino)propoxy)phenyl)-butyric acid, used for prophylaxis of tumors, osteoporosis, cardiovascular diseases, fibrosis, inflammation, infections or psoriasis MERCK PATENT GMBH (DE) 2003-11-11 US disclosed